Literature DB >> 28295521

Exacerbation of infliximab-induced paradoxical psoriasis after ustekinumab therapy.

Hyun Yi Suh1, Ji Young Ahn1, Mi Youn Park1, Jai Il Youn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28295521     DOI： 10.1111/1346-8138.13803

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  4 in total

Review 1.  Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn's disease-associated spondyloarthropathy.

Authors:  Michael Benzaquen; Benoit Flachaire; Frank Rouby; Philippe Berbis; Sandrine Guis
Journal:  Rheumatol Int       Date:  2018-04-28       Impact factor: 2.631

Review 2.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

3.  TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.

Authors:  Sara Jiayang Li; Lourdes M Perez-Chada; Joseph F Merola
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-11-21

Review 4.  Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.

Authors:  Aranzazu Jauregui-Amezaga; Michael Somers; Heiko De Schepper; Elisabeth Macken
Journal:  Clin Exp Gastroenterol       Date:  2017-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.